168 related articles for article (PubMed ID: 22568711)
21. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
[TBL] [Abstract][Full Text] [Related]
22. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
[TBL] [Abstract][Full Text] [Related]
23. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
[TBL] [Abstract][Full Text] [Related]
24. Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis.
Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):274-80. PubMed ID: 25415288
[TBL] [Abstract][Full Text] [Related]
25. Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.
Mapamba DA; Sauli E; Lalashowi J; Buza J; John J; Mwaisango Z; Tarmo P; Sabi I; Rachow A; Ntinginya NE; Mtafya B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835127
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
García JI; Meléndez J; Álvarez R; Mejía-Chew C; Kelley HV; Sidiki S; Castillo A; Mazariegos C; López-Téllez C; Forno D; Ayala N; Balada-Llasat JM; Mejía-Villatoro CR; Wang SH; Torrelles JB; Ikeda J
AIDS Res Ther; 2020 Oct; 17(1):62. PubMed ID: 33076996
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data.
Broger T; Koeppel L; Huerga H; Miller P; Gupta-Wright A; Blanc FX; Esmail A; Reeve BWP; Floridia M; Kerkhoff AD; Ciccacci F; Kasaro MP; Thit SS; Bastard M; Ferlazzo G; Yoon C; Van Hoving DJ; Sossen B; García JI; Cummings MJ; Wake RM; Hanson J; Cattamanchi A; Meintjes G; Maartens G; Wood R; Theron G; Dheda K; Olaru ID; Denkinger CM;
Lancet Glob Health; 2023 Jun; 11(6):e903-e916. PubMed ID: 37202025
[TBL] [Abstract][Full Text] [Related]
28. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):289-94. PubMed ID: 22531759
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
Shah M; Variava E; Holmes CB; Coppin A; Golub JE; McCallum J; Wong M; Luke B; Martin DJ; Chaisson RE; Dorman SE; Martinson NA
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):145-51. PubMed ID: 19692904
[TBL] [Abstract][Full Text] [Related]
30. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
[TBL] [Abstract][Full Text] [Related]
32. Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region.
Drain PK; Gounder L; Sahid F; Moosa MY
Sci Rep; 2016 Feb; 6():19992. PubMed ID: 26865526
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
Shah M; Dowdy D; Joloba M; Ssengooba W; Manabe YC; Ellner J; Dorman SE
AIDS; 2013 Nov; 27(18):2883-92. PubMed ID: 25119690
[TBL] [Abstract][Full Text] [Related]
34. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.
Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
BMC Pulm Med; 2016 Nov; 16(1):147. PubMed ID: 27842535
[TBL] [Abstract][Full Text] [Related]
35. Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?
Peter JG; Theron G; Dheda K
PLoS One; 2013; 8(2):e54875. PubMed ID: 23390504
[TBL] [Abstract][Full Text] [Related]
36. Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.
Qvist T; Johansen IS; Pressler T; Høiby N; Andersen AB; Katzenstein TL; Bjerrum S
BMC Infect Dis; 2014 Dec; 14():655. PubMed ID: 25471640
[TBL] [Abstract][Full Text] [Related]
37. Point-of-care urine lipoarabinomannan antigen detection for diagnosis of tuberculosis in children.
Gautam H; Singla M; Jain R; Lodha R; Kabra SK; Singh UB
Int J Tuberc Lung Dis; 2019 Jun; 23(6):714-719. PubMed ID: 31315704
[TBL] [Abstract][Full Text] [Related]
38. Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
Younis H; Kerschbaumer I; Moon JY; Kim RS; Blanc CJ; Chen T; Wood R; Lawn S; Achkar JM
PLoS One; 2019; 14(6):e0218606. PubMed ID: 31237915
[TBL] [Abstract][Full Text] [Related]
39. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
[TBL] [Abstract][Full Text] [Related]
40. Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
Connelly JT; Andama A; Grant BD; Ball A; Mwebe S; Asege L; Nakaye M; Lopez BB; Hsieh HV; Katumba D; Mukwatamundu J; Nalubega M; Hunt VM; Burkot S; Ramachandraiah H; Choudhary A; Ignatowicz L; Weigl BH; Bachman C; Mulondo J; Semitala F; Worodria W; Pinter A; Hamasur B; Bell D; Cattamanchi A; Somoskovi A
PLoS One; 2021; 16(7):e0254156. PubMed ID: 34310609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
